Skip to main content
. 2007 Sep;5(3):168–179. doi: 10.2174/157015907781695928

Table 1.

Human Class B GPCR’s and Their Peptide Ligands

Receptor Peptide Ligand Principal Biological Action Major Disease Indication Peptide Therapeutic Refs.
CRF1 CRF
UCN 1
Stress responses
Stress responses
Depression (antagonist) [2,43, 92]
CRF2 UCN 1
UCN 2
UCN 3
Stress responses
Cardiac contractility
Hearing
Heart failure (agonist) [2]
GHRH GHRH Growth hormone release [52,77]
GIP GIP Insulin secretion Type 2 diabetes (agonist) [52,77]
Glucagon Glucagon Glucose homeostasis Type 2 diabetes (antagonist) [52,77]
GLP-1 GLP-1 Insulin secretion Type 2 diabetes (agonist) Byetta (Exanatide) [19,52,77]
GLP-2 GLP-2 Gut mucosal growth [52,77]
PTH1 PTH
PTHrP
Ca2+ homeostasis
Developmental regulator
Osteoporosis (agonist) Forteo (PTH(1-34)) [5,58,73, 90]
PTH2 TIP39 Hypothalamic secretion,Nociception [88]
Secretin Secretin Pancreatic secretion [52,77]
VPAC1 VIP
PACAP
Neuroendocrine functions
Neuroendocrine functions
[30,77]
VPAC2 VIP
PACAP
Neuroendocrine functions
Neuroendocrine functions
[30,77]
PAC1 PACAP Neuroendocrine functions [30,77]
Calcitonin Calcitonin Ca2+ homeostasis Osteoporosis (agonist) Miacalcin (calcitonin) [54]
Calcitonin/ RAMP1 CGRP
Amylin
Vasodilation
Feeding
Migraine (antagonist) [57,67]
Calcitonin / RAMP3 Amylin Feeding [57,67]
CL / RAMP1 CGRP Vasodilation [57,67]
CL / RAMP2 Adrenomedullin Vasodilation [57,67]
CL / RAMP3 Adrenomedullin
CGRP
Vasodilation
Vasodilation
[57,67]

Abbreviations:CRF- corticotropin-releasing factor; UCN - urocortin; GHRH - growth hormone-releasing hormone; GIP - glucose-dependent insulinotropic peptide; GLP - glucago nlike peptide;PTH- parathyroidhormone;PTHrP - parathyroid hormone-related protein; TIP39 - tuberoinfundibular peptide of 39 residues; VIP - vasoactive intestinal peptide; PACAP- pituitary adenylate cyclase-activating polypeptide; CGRP - calcitonin gene-related peptide; RAMP - receptor activity modifying protein; CL - calcitonin receptor-like receptor.